End of Government Purchases May Make COVID Drugs Less Lucrative

September 9, 2022

(Axios) – Dwindling public demand for COVID vaccines and private market pressures should combine to cost manufacturers billions of dollars once the federal government stops buying the shots, eating into Pfizer and Moderna’s pandemic profits. Between the lines: The federal government bought far more vaccine than Americans would ever use to ensure that vaccine would be accessible. But private purchasers won’t tolerate redundancy or waste. (Read More)